 random trial cisplatin-contain treatment patient metastat non-small-cel lung cancer southwest oncolog group studi six assess patient measur stage iii non-small-cel lung cancer nsclc treatment arm cisplatin methylglyox bisguanylhydrazon mgbg pvp pvpm cisplatin vinblastin pve vinblastin mitomycin pvemi vincristin mitomycin/cyclophosphamid doxorubicin cisplatin fomi/cap overal respons rate complet respons partial remiss durat respons differ treatment regimen month month overal median surviv patient month differ treatment toxic pvpm similar result respons durat respons surviv superior platinum-bas regimen standard clinic usag